Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Pulmonary Embolism

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

March 10, 2023

C. Noel Bairey Merz, MD, Director of the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute, received the distinguished achievement of Master of the ACC (MACC) on March 6 during Annual Scientific Session

News | ACC

American College of Cardiology Honors Women’s Heart Disease Pioneer

March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...

March 09, 2023

Use of an antihypertensive to lower blood pressure in obese patients was found effective, according to Target-HTN Trial results presented during the 2023 American College of Cardiology Scientific Session.

News | ACC

Data from Target-HTN Trial Released at ACC23 Supports Use of Antihypertensive to Reduce Blood Pressure in Obese Patients

March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...

March 09, 2023

B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology.

News | ACC

Dr. B. Hadley Wilson is new American College of Cardiology President

March 8, 2023 — B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology. Today marks the ...

March 08, 2023

A study to better understand the association between Lipoprotein(a), Lp(a) levels and artherosclerotic cardiovascular disease (ASCVD) in an underrepresented population has been announced by Amgen, which will be working with the Association of Black Cardiologists and the Morehouse School of Medicine on the African American Heart Study.

News | Cardiovascular Clinical Studies

African American Heart Study Announced by Amgen, in Collaboration with Association of Black Cardiologists and Morehouse School of Medicine

March 8, 2023 — A unique community-based partnership, the African American Heart Study, will be conducted to measure the ...

March 08, 2023

Analysis finds most athletes had no cardiac events over seven years, underscoring importance of shared decision-making

News | Implantable Cardioverter Defibrillator (ICD)

Cardiac Risks Appear Low for Elite Athletes with Diagnosed, Treated Genetic Heart Disease

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

March 07, 2023

Kelly Chin, MD, professor of medicine and director of the pulmonary hypertension program at UT Southwestern Medical Center in Dallas

News | Hypertension

Fixed-Dose Combination Pill Outperforms Monotherapy for Pulmonary Hypertension

March 6, 2023 — Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the lungs ...

March 06, 2023

Virtual Care Team-Guided Strategy was found to optimize GDMT for hospitalized HF patients according to results of the multi-center IMPLEMENT-HF Trial presented at ACC 23/WCC during a March 6 Featured Clinical Research session.

News | ACC

Virtual Care Team-Guided Strategy Optimizes GDMT for Hospitalized HF Patients in IMPLEMENT-HF Trial, According to Multi-Center Study Presented at ACC 23

March 7, 2023 — A virtual care team-guided strategy for guideline-directed medical therapy (GDMT) optimization was found ...

March 06, 2023

Brian A. Ference, MD, MPhil, MSc, professor and director of translational therapeutics at the University of Cambridge in the United Kingdom

News | Artificial Intelligence

AI Provides Personalized Guidance Based on Inherited Risk of Heart Disease

March 5, 2023 — Researchers demonstrated that a causal artificial intelligence (AI) system can accurately quantify how ...

March 05, 2023

Amrita Mukhopadhyay, MD, cardiologist and clinical investigator at NYU Grossman School of Medicine in New York City

News | Heart Failure

Prescribing of Key Heart Failure Medications Improved with Tailored Digital Alerts

March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...

March 05, 2023

COAPT trial demonstrates long-term benefits of transcatheter procedure in high-risk patients with heart failure

News | Structural Heart

Minimally Invasive Mitral Valve Repair Reduces Hospitalizations and Deaths

March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...

March 05, 2023

The Opening Showcase of the American College of Cardiology's Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, featured comments from Ed Fry, MD, ACC President, shown here, the event Chair and World Heart Federation President. the 3-day global gathering of cardiologists is taking place March 4-6 in New Orleans, LA.

Feature | ACC | Christine Book

Important Clinical Trial Outcomes, the Evolution of Cardiac ICU and Young Authors Take Center Stage for Global Gathering of Cardiologists in New Orleans ACC.23/WCC

March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the American ...

March 04, 2023

Statistically significant reduction in the risk for the primary outcome on Day 27

News | Heart Failure

New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at ACC23

March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...

March 04, 2023

Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)

News | Structural Heart

New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

March 04, 2023

News | ACC

GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC

March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning ...

March 04, 2023